Back to Search
Start Over
Puma Biotechnology Presents Interim Results from the Biliary Tract Cancers Cohort of the Phase II SUMMIT 'Basket' Trial of Neratinib at ASCO GI
- Source :
- Business Wire. January 15, 2021
- Publication Year :
- 2021
-
Abstract
- LOS ANGELES -- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced interim results from the biliary tract cancers cohort of the ongoing SUMMIT trial of neratinib at the virtual [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.648446938